医药行业分析
- (2023-07-31)
- (2023-07-31)
- (2023-07-31)
- (2023-07-31)
- (2023-07-31)
- (2023-07-31)
- (2023-07-31)
- (2023-07-31)
- (2023-07-31)
- (2023-07-31)
- (2023-07-28)
- (2023-07-28)
- (2023-07-28)
- (2023-07-28)
- (2023-07-28)
- (2023-07-28)
- (2023-07-28)
- (2023-07-28)
- (2023-07-28)
- (2023-07-28)
- (2023-07-27)
- (2023-07-27)
- (2023-07-27)
- (2023-07-27)
- (2023-07-27)
- (2023-07-27)
- (2023-07-27)
- (2023-07-27)
- (2023-07-26)
- (2023-07-26)
- (2023-07-26)
- (2023-07-26)
- (2023-07-26)
- (2023-07-26)
- (2023-07-26)
- (2023-07-26)
- (2023-07-26)
- (2023-07-26)
- (2023-07-26)
- (2023-07-26)
- (2023-07-26)
- (2023-07-26)
- (2023-07-25)
Cell Death and Disease: p75NTR是一个用于开发对抗阿糖胞苷介导的成熟神经元细胞死亡的治疗新的分子靶点
(2023-07-25)- (2023-07-25)
- (2023-07-25)
- (2023-07-25)
- (2023-07-25)
- (2023-07-25)
- (2023-07-25)
- (2023-07-24)
- (2023-07-24)
- (2023-07-24)
- (2023-07-24)
- (2023-07-24)
- (2023-07-24)
- (2023-07-24)
- (2023-07-24)
- (2023-07-24)
- (2023-07-24)